Why is it important to consider a gender perspective in the drugs field? What do the data tell us about the main gender differences in drug use and drug-related harms in Europe? Is the gender gap in drug use narrowing among younger generations? How can gender-responsive interventions be implemented in the drugs field?
These are just some of the questions posed in our Frequently asked questions (FAQ): gender and drugs in Europe published today.
The new resource provides answers to important questions on gender and drugs, with a particular focus on the European situation…
Read more
On World Energy Efficiency Day, we are delighted to announce that the EUDA has been officially registered under the EU Eco-Management and Audit Scheme (EMAS), in recognition of its commitment to reducing its environmental impact.
EMAS is the EU voluntary instrument for environmental management and auditing, which allows organisations to evaluate, report on, and continuously improve their environmental performance. Registration is valid for three years and can be renewed following a successful reassessment.
Environmental management has been an integral part of our operations for over a…
Read more
Preparing Europe for current and future drug challenges is at the heart of our mission. Our new Single programming document 2026–2028, published today, sets out how we will enhance EU preparedness through better data, faster alerts, clearer insights and a strong focus on learning, innovation and collaboration.
Introducing the publication, EUDA Executive Director, Dr Lorraine Nolan…
Read more
